RU99123816A - METHOD FOR ADDING HIV INFECTION - Google Patents
METHOD FOR ADDING HIV INFECTIONInfo
- Publication number
- RU99123816A RU99123816A RU99123816/14A RU99123816A RU99123816A RU 99123816 A RU99123816 A RU 99123816A RU 99123816/14 A RU99123816/14 A RU 99123816/14A RU 99123816 A RU99123816 A RU 99123816A RU 99123816 A RU99123816 A RU 99123816A
- Authority
- RU
- Russia
- Prior art keywords
- ozonized
- ozone
- oil
- fat emulsion
- aqueous solution
- Prior art date
Links
- 208000005721 HIV Infections Diseases 0.000 title claims 2
- 201000001820 human immunodeficiency virus infectious disease Diseases 0.000 title claims 2
- CBENFWSGALASAD-UHFFFAOYSA-N ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims 10
- 239000002960 lipid emulsion Substances 0.000 claims 7
- 239000007864 aqueous solution Substances 0.000 claims 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 6
- 239000007788 liquid Substances 0.000 claims 4
- 239000003921 oil Substances 0.000 claims 4
- 239000000443 aerosol Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 235000019198 oils Nutrition 0.000 claims 3
- 210000004369 Blood Anatomy 0.000 claims 2
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 claims 2
- 238000005273 aeration Methods 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 230000005587 bubbling Effects 0.000 claims 2
- 239000007789 gas Substances 0.000 claims 2
- 238000005470 impregnation Methods 0.000 claims 2
- YNHBOQSCVCFXRW-UHFFFAOYSA-N ozone;hydrate Chemical compound O.[O-][O+]=O YNHBOQSCVCFXRW-UHFFFAOYSA-N 0.000 claims 2
- 150000002978 peroxides Chemical class 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 238000005507 spraying Methods 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 238000002604 ultrasonography Methods 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 210000002751 Lymph Anatomy 0.000 claims 1
- 210000004324 Lymphatic System Anatomy 0.000 claims 1
- 210000003097 Mucus Anatomy 0.000 claims 1
- 229940067631 Phospholipids Drugs 0.000 claims 1
- 210000000664 Rectum Anatomy 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000007792 gaseous phase Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000012071 phase Substances 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 235000012424 soybean oil Nutrition 0.000 claims 1
- 239000003549 soybean oil Substances 0.000 claims 1
- 239000008347 soybean phospholipid Substances 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 210000001519 tissues Anatomy 0.000 claims 1
Claims (6)
Соевое масло озонированное с пероксидным числом Р- не менее 500 - 7,5
Рафинированный соевый лецитин (фосфолипиды) - 1,2
Глицерин - 2,5
Дистиллят или пропиллент - Остальное до 100,0
7. Способ по пп.1 и 2, отличающийся тем, что инсуфляцию полостей организма озоно-кислородной или озонсодержащей газовоздушной смесями осуществляют при концентрации в них озона не более 20 мг/л.6. The method according to PP.1 and 2, characterized in that the aerosol ozonized fat emulsion of the type "oil in water" is obtained by their pneumatic spraying using the composition in the following ratio, wt.%:
The soybean oil ozonized with a peroxide number of P is not less than 500 - 7.5
Refined soy lecithin (phospholipids) - 1,2
Glycerin - 2.5
Distillate or propylene - Else up to 100.0
7. The method according to claims 1 and 2, characterized in that the insufflation of the body cavities with ozone-oxygen or ozone-containing gas-air mixtures is carried out at an ozone concentration of no more than 20 mg / l.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU99123816A RU2198664C2 (en) | 1999-11-12 | 1999-11-12 | Method for suppressing hiv-infection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU99123816A RU2198664C2 (en) | 1999-11-12 | 1999-11-12 | Method for suppressing hiv-infection |
Publications (2)
Publication Number | Publication Date |
---|---|
RU99123816A true RU99123816A (en) | 2001-08-10 |
RU2198664C2 RU2198664C2 (en) | 2003-02-20 |
Family
ID=20226882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99123816A RU2198664C2 (en) | 1999-11-12 | 1999-11-12 | Method for suppressing hiv-infection |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2198664C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019240713A2 (en) * | 2018-03-29 | 2019-12-19 | Sabanci Ahmet Uemit | Solutions comprising ozonized oil |
-
1999
- 1999-11-12 RU RU99123816A patent/RU2198664C2/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Norheim | Adverse effects of acupuncture: a study of the literature for the years 1981-1994 | |
DE60112102T2 (en) | COMBINATION OF A NO-DONOR AND ANTIOXIDANE FOR THE TREATMENT OF SEXUAL DISORDERS | |
Salter et al. | Hydrocortisone arthropathy--an experimental investigation. | |
US7347944B2 (en) | Method for making and conditioning super-oxygenated and structured water | |
RU2126262C1 (en) | Pharmaceutical composition | |
US5891915A (en) | Method for enhancing female sexual response and an ointment therefor | |
JP2020040958A (en) | Novel formulations of volatile anesthetics and methods of use thereof for reducing inflammation | |
Bocci et al. | Mechanisms of action and chemical-biological interactions between ozone and body compartments: a critical appraisal of the different administration routes | |
Abrahams et al. | Fatal Case of Acute Porphyria | |
JPWO2004052338A1 (en) | Biological cavity cleaning agent, biological cavity cleaning apparatus, and biological cavity cleaning method | |
RU99123816A (en) | METHOD FOR ADDING HIV INFECTION | |
US20020035141A1 (en) | Use of melatonin for induction of general anesthesia | |
RU76804U1 (en) | DEVICE FOR OZONE / NO-ULTRASONIC TREATMENT OF SKY ALMONDS IN CONSERVATIVE TREATMENT OF CHRONIC TONZILLITIS | |
RU2141313C1 (en) | Pharmaceutical emulsion containing biologically active steroids and method of emulsion preparing | |
RU2198664C2 (en) | Method for suppressing hiv-infection | |
MD2354G2 (en) | Method of treatment of the hepatic encephalopathy | |
RU2099061C1 (en) | Method for treating the cases of neurodermite | |
CN2728496Y (en) | Gas liquid mixer of device for immediately generating ozone solution for use | |
JPH06172205A (en) | Fat emulsifier containing acreasin compounds | |
JPH044300B2 (en) | ||
MARVIN | The Therapy of Dropsy | |
GB2095992A (en) | Psycotropic drugs containing caerulein | |
Kaufman | Spiramycin | |
CN105596362A (en) | Energy liquid powder mineral supplement and activation method | |
US20020120002A1 (en) | Use of melatonin analogues for induction of general anesthesia |